Development to tolerance of and dependence on endogenous neurotransmitters.
D006916:5-Hydroxytryptophan / Q000378:metabolism / Q000494:pharmacology; D000109:Acetylcholine / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D000328:Adult; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001923:Brain Chemistry; D002395:Catecholamines / Q000494:pharmacology; D004361:Drug Tolerance; D006801:Humans; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology; D019966:Substance-Related Disorders / Q000209:etiology*; D009435:Synaptic Transmission
D014150:Antipsychotic Agents; D002395:Catecholamines; D008781:Methyltyrosines; D018377:Neurotransmitter Agents; D012701:Serotonin; D006916:5-Hydroxytryptophan; D000109:Acetylcholine